The Scientist - Home

PALMERSTON NORTH, N.Z.—The head of the major trade union representing scientists and technologists in Britain has denounced "the failure of successive British governments, particularly the present Conservative administration, to provide sufficient funds for science and for R&D, or to take a positive lead in drawing up a national strategy for science." Speaking at the ANZAAS Congress here last month, Clive Jenkins, general secretary of the Association of Scientific, Technical and Managerial

PARIS—The recent decision by the French government to ban for three years any genetic manipulation of the human embryo within the country's leading research centers follows a recommendation from its own expert committee on bioethical questions. The ability to shape public policy has been a hallmark of the committee since it was formed in 1983. Its report, denouncing a "zeal to procreate" among some segments of society, warned that current advances in genetics could be exploited in eugenics

BOSTON—The company that agreed to market the world's first genetically engineered pseudorabies livestock vaccine has charged the vaccine's developer with "fraudulent misrepresentation" of the vaccine's safety and efficacy. According to a claim filed November 13 in U.S. District Court in Houston, TechAmerica Group Inc. would not have entered into its agreement with Novagene Ltd. "had it known the truth with regard to such statements, representations and omissions" in the data presented on t

FRANKFURT—The message from last month's national elections is that the environmental Green party can no longer be dismissed as a temporary phenomenon. But it is still too soon to know whether it can translate its electoral gains into an ability to influence government policies on scientific research. Part of that answer lies in whether the Greens join with the Social Democrats (SPD) and succeed in incorporating their views into formal opposition to the ruling coalition of Christian Democra

NEW YORK—A 200-gallon aquarium isn't much to brag about. But the tank, together with workstations, microscopes, displays and a helpful staff, have made quite a splash at the new New York Hall of Science in Queens. The aquarium is one of more than 100 exhibits at the museum, which formally reopened its doors last fall after a five-year, $9 million renovation and a summer-long dress rehearsal. Like the museum itself, the aquarium exhibit is designed to "bring the microscope into the macrosco

WASHINGTON—Maxine Frank Singer, chief of the biochemistry laboratory at NIH's National Cancer Institute, has been named the next president of the Carnegie Institution of Washington. Singer, a molecular biologist, will succeed James Ebert, who has been president since 1978. Founded by Andrew Carnegie in 1902, the private, nonprofit Institution has an annual budget of $16 million. It supports research in biology, astronomy and the earth sciences by 60 scientists and 120 fellows at five cente

SANTA FE, N.M.—The Department of Energy believes robotics and other automated processes can free molecular biologists from much of the tedious work now performed manually in their laboratories. But responses among the 160 scientists, technicians and research administrators who attended a workshop on the subject here last month suggest the department needs to work on its sales pitch. The three-day meeting was organized by Tony Beugelsdijk, a chemist specializing in laboratory robotics at Lo

LONDON—Proponents of nuclear power received a boost recently with the recommendation of a government panel to build a pressurized water reactor at Sizewell in Suffolk. The 3,000-page report, written by Sir Frank Layfield, a planning lawyer, is the product of a four-year inquiry into the subject. Rob Campbell, the managing director of Babcock Power, a manufacturer of steam generators, said the report "signals the light at the end of the tunnel" after a decade of anti-nuclear protests. The p

WASHINGTON—The 100th Congress has tried to set the tone of political debate in the country by moving quickly on several issues in its first few weeks. Its science panels have been equally quick to assemble their own agenda for the coming months. One group that is certain to vie for the spotlight is a new task force on technology policy that will encompass the effect of current practices on scientific R&D in the United States. The group, expected to be chaired by Rep. Buddy MacKay (D-Fla.),

WASHINGTON—The hiatus in U.S. unmanned planetary missions, caused by the explosion 13 months ago of the Space Shuttle Challenger, has made it possible for NASA's Jet Propulsion Laboratory (JPL) in Pasadena to take on a new role as manager for a portion of the agency's troubled space station program. The loss of Challenger has delayed for several years planned missions to Venus, Mars, Jupiter and explorations of the sun that will be carried out by the Laboratory, which is operated by the Ca

WASHINGTON—The idea of making American industry more competitive through increased support for industrial and academic research and development is becoming a rallying cry for high-powered lobbying efforts here. This winter has seen the birth of two privately funded, independent coalitions that unite members of high-tech industries, universities, trade associations and nonprofit organizations. It has also seen the formation of a 160-member Congressional Caucus on Competitiveness, and the in

WASHINGTON—Next week's annual meeting in Chicago will permit the American Association for the Advancement of Science to carry out its fundamental mission of promoting the public understanding of science. But something of even greater importance to the 139-year-old organization will take place after the meeting, when a successor to Executive Director William Carey will be announced. Carey, 70, is retiring March 31 after serving for a dozen years as head of the oldest, largest and most prest